See also this year's filing and all EDGAR filings for this company.
PDF Report 0000875622_2016_Biospecifics_Technologies_CORP.pdf
Logs
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0000875622, Biospecifics Technologies CORP
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 38,368,882 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 275,206 |
| 2 | PropertyPlantAndEquipmentNet | 0 |
| 3 | remainder_Assets | 7,054,025 |
| 4 | LiabilitiesCurrent | 838,525 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 7,214,267 |
| 9 | ResearchAndDevelopmentExpense | 937,874 |
| 10 | remainder_Expenses | 4,401,217 |
| 11 | remainder_Revenues | 22,264,579 |
| 12 | remainder_NetIncome | 91,253 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 45,698,113 |
| 1 | Liabilities | 838,525 |
| 2 | Expenses | 12,553,358 |
| 3 | Revenues | 22,264,579 |
| 4 | StockholdersEquity | 44,859,588 |
| 5 | NetIncome | 9,802,474 |
| 6 | ComprehensiveNetIncome | 9,802,474 |
| 7 | BaseVar | 40,722,914 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 4.62 |
| 9 | EconomicCapitalRatio | 4.88 |
Edgar->Model Mapping
Feature Distribution
Change over Time
